ED&I in Precision Medicine

Advancing the Ever-Evolving ED&I Movement Within the Precision Medicine Community to Foster Collaboration, Advocate Membership & Accelerate Innovation to Meaningfully Embed Inclusion Within Personalized Healthcare

This Event Ran Monday, 27 September
8.30am - 12.30pm EDT | 5.30am – 9.30am PDT

4 years on from when the #MeToo movement got reignited, a year on from when the world united behind the BLM movement, and in a year still reeling from the effects of COVID19, how do we continue to shine a light on the crucial and ever-evolving ED&I conversations?

For the third consecutive year, the Equity, Diversity & Inclusion in Precision Medicine workshop brought together 450+ global precision medicine decision makers to continue the movement and drive forward our community’s commitment to ED&I within our teams, functions and wider businesses.

With 30+ precision medicine leaders joining the 2021 expert speaker faculty, this event sharpened leadership skills and showcased the tools to create inclusive and empowering working environments within your organizations. Industry leaders gathered to advance the ever-evolving ED&I movement within the precision medicine community to foster collaboration, advocate membership and accelerate innovation to meaningfully embed inclusion within personalized healthcare.

What Was Discussed?

Screenshot 2021-07-29 152144

The Key to Success – Becoming a Culturally Intelligent Global Organization

Screenshot 2021-07-29 152144

Effective Leadership & Mentorship Structures to Foster Diversity, Equity & Inclusion Across Your Organization

Screenshot 2021-07-29 152144

From Making Your Pledge to Implementation: How Is Your Organization Embedding Diversity, Equity & Inclusion Across All Internal Layers?

Screenshot 2021-07-29 152144

Transforming the Recruitment Process & Returning To Work In the Post-COVID19 Era – Further Accelerating Our Industry’s Journey to Becoming Truly Equal, Diverse & Inclusive

Your Expert Speakers Include:

Anindya Sen

Director, Research & Development

Prevail Therapeutics

Candy Gee

Diversity & Inclusion Partner

Roche Diagnostic Operations

Cecília Schott

Vice President, Global Head Precision Medicine, Oncology Business Unit

Novartis

Zheng Feng

Director & Head of Molecular Biomarker & Genomics, Global Clinical Biomarkers & Companion Diagnostics

EMD Serono

Cindy Perettie

Head of Roche Molecular Labs

Roche Diagnostic Solutions

Craig Eagle

Chief Medical Officer

Guardant Health

Deborah Shepard

Director, Biomarker Clinical Assay Lead

Pfizer

Elizabeth Attias

Chief Strategy & Development Officer

Sermonix Pharmaceuticals

Ellie Corigliano

Head of CDx Cell & Gene Therapies Oncology

GlaxoSmithKline

Jaime Boyle

Vice President, BioPharma Business Development

Guardant Health

Janine Ting Jansen

Senior Director of Inclusion & Diversity, North America

Teva Pharmaceuticals

Jennifer Higgins

Vice President, Public Affairs

Guardant Health

Jill German

Head of Pathology Customer Area

Roche Diagnostic Solutions

Katherine Block

Director, Biomarker Sciences

Sangamo Therapeutics

Kathryn Lang

Vice President, Outcomes & Evidence

Guardant Health

Kaye Foster

Senior Advisor & Executive Coach

The Boston Consulting Group (BCG)

Kirsteen Maclean

Senior Director of Biomarker & Translational Strategy

Ultivue

Madhushree Ghosh

Vice President, Strategic Alliances & Projects BioPharma Services

NeoGenomics Laboratories

Marielena Mata

Senior Director & Diagnostic Lead

Pfizer

Megan Ann Greenfield

Partner

McKinsey & Company

Michelle Zhang

Senior Vice President, Translational Research & Early Development

Ikena Oncology

Mike Tang

Senior Vice President & General Counsel

Agilent Technologies

Padraig McDonnell

President, Agilent CrossLab Group

Agilent Technologies

Patrice Jimerson

Associate Vice President, Diversity & Inclusion

Agilent Technologies

Samik Basu

Vice President, Preclinical & Translational Research

Cabaletta Bio

Sarah Hersey

Vice President, Precision Medicine

Bristol Myers Squibb

Scott Patterson

Vice President, Biomarker Sciences

Gilead Sciences

Shirin Hasan

Associate Vice President, Head of Global Clinical Affairs

Agilent Technologies

Faswilla Sampson

Vice President of Operations

Personalized Medicine Coalition

Siddha Kasar

Associate Director, Clinical Translational Lead, Cell Therapies

Takeda

Simi Ahmed

Senior Vice President

The New York Stem Cell Foundation

Susanne Munksted

Chief Precision Officer

Diaceutics

Brought to You in Proud Partnership With:

Ultivue
Geonomics
Roche Logo
Guardant Health
agilent
abbott